
    
      This is a two-part study.

      Part 1:

      Part 1 of the study is a single-dose, dose-escalation, study to assess the safety,
      tolerability and PK profiles following oral administrations of FDL169 to healthy female
      volunteers in the fed state. Up to five doses will be assessed.

      Part 2:

      Part 2 of the study is a multiple-dose study to assess the safety, tolerability and PK
      profiles following oral administrations of FDL169 to healthy female volunteers in the fed
      state.
    
  